Artículos de revistas
Plasma Fibrinogen: Now Also An Antidepressant Response Marker?
Registro en:
Translational Psychiatry. , v. 4, n. , p. - , 2014.
21583188
10.1038/tp.2013.129
2-s2.0-84893354179
Autor
Martins-De-Souza D.
Maccarrone G.
Ising M.
Kloiber S.
Lucae S.
Holsboer F.
Turck C.W.
Institución
Resumen
Major depressive disorder (MDD) is one of the leading causes of global disability. It is a risk factor for noncompliance with medical treatment, with about 40% of patients not responding to currently used antidepressant drugs. The identification and clinical implementation of biomarkers that can indicate the likelihood of treatment response are needed in order to predict which patients will benefit from an antidepressant drug. While analyzing the blood plasma proteome collected from MDD patients before the initiation of antidepressant medication, we observed different fibrinogen alpha (FGA) levels between drug responders and nonresponders. These results were replicated in a second set of patients. Our findings lend further support to a recently identified association between MDD and fibrinogen levels from a large-scale study. © 2014 Macmillan Publishers Limited. 4
DiMatteo, M.R., Lepper, H.S., Croghan, T.W., Depression is a risk factor for noncompliance with medical treatment meta-analysis of the effects of anxiety and depression on patient adherence (2000) Archives of Internal Medicine, 160 (14), pp. 2101-2107 Rosenzweig-Lipson, S., Beyer, C.E., Hughes, Z.A., Khawaja, X., Rajarao, S.J., Malberg, J.E., Rahman, Z., Schechter, L.E., Differentiating antidepressants of the future: Efficacy and safety (2007) Pharmacology and Therapeutics, 113 (1), pp. 134-153. , DOI 10.1016/j.pharmthera.2006.07.002, PII S0163725806001331 Nrugham, L., Holen, A., Sund, A.M., Suicide attempters and repeaters: Depression and coping: A prospective study of early adolescents followed up as young adults (2012) J Nerv Ment Dis, 200, pp. 197-203 Martins-de-Souza, D., Harris, L.W., Guest, P.C., Turck, C.W., Bahn, S., The role of proteomics in depression research (2010) Eur Arch Psy Clin Neurosci, 260, pp. 499-506 Wium-Andersen, M.K., Orsted, D.D., Nordestgaard, B.G., Association between elevated plasma fibrinogen and psychological distress, and depression in 73 367 individuals from the general population (2012) Mol Psychiatry, 18, pp. 854-855 Hennings, J.M., Owashi, T., Binder, E.B., Horstmann, S., Menke, A., Kloiber, S., Clinical characteristics and treatment outcome in a representative sample of depressed inpatients -Findings from the munich antidepressant response signature (mars) project (2009) J Psychiatr Res, 43, pp. 215-229 Wium-Andersen, M.K., Orsted, D.D., Nordestgaard, B.G., Elevated plasma fibrinogen, psychological distress, antidepressant use, and hospitalization with depression: Two large population-based studies (2012) Psychoneuroendocrinology, 38, pp. 638-647 Panagiotakos, D.B., Pitsavos, C., Chrysohoou, C., Tsetsekou, E., Papageorgiou, C., Christodoulou, G., Stefanadis, C., Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people the ATTICA study (2004) European Heart Journal, 25 (6), pp. 492-499. , DOI 10.1016/j.ehj.2004.01.018 Maes, M., Delange, J., Ranjan, R., Meltzer, H.Y., Desnyder, R., Cooremans, W., Scharpe, S., Acute phase proteins in schizophrenia, mania and major depression: Modulation by psychotropic drugs (1997) Psychiatry Research, 66 (1), pp. 1-11. , DOI 10.1016/S0165-1781(96)02915-0, PII S016517819602915 Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E.K., A metaanalysis of cytokines in major depression (2010) Biol Psychiatry, 67, pp. 446-457 Howren, M.B., Lamkin, D.M., Suls, J., Associations of depression with c-reactive protein, il-1, and il-6: A meta-analysis (2009) Psychosom Med, 71, pp. 171-186 Krishnadas, R., Cavanagh, J., Depression: An inflammatory illness? (2012) J Neurol Neurosurg Psychiatry, 83, pp. 495-502 Muller, N., Myint, A.M., Schwarz, M.J., Inflammatory biomarkers and depression (2011) Neurotox Res, 19, pp. 308-318 Dantzer, R., O'Connor, J.C., Lawson, M.A., Kelley, K.W., Inflammation-associated depression: From serotonin to kynurenine (2011) Psychoneuroendocrinology, 36, pp. 426-436 Duivis, H.E., De Jonge, P., Penninx, B.W., Na, B.Y., Cohen, B.E., Whooley, M.A., Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: Prospective findings from the heart and soul study (2011) Am J Psychiatry, 168, pp. 913-920 Baune, B.T., Neuhauser, H., Ellert, U., Berger, K., The role of the inflammatory markers ferritin, transferrin and fibrinogen in the relationship between major depression and cardiovascular disorders -The german health interview and examination survey (2010) Acta Psychiatr Scand, 121, pp. 135-142 Vasse, M., Paysant, J., Soria, J., Collet, J.P., Vannier, J.P., Soria, C., Regulation of fibrinogen biosynthesis by cytokines, consequences on the vascular risk (1996) Haemostasis, 26 (SUPPL. 4), pp. 331-339 Miller, A.H., Maletic, V., Raison, C.L., Inflammation and its discontents: The role of cytokines in the pathophysiology of major depression (2009) Biol Psychiatry, 65, pp. 732-741 Catena-Dell'Osso, M., Rotella, F., Dell'Osso, A., Fagiolini, A., Marazziti, D., Inflammation, serotonin and major depression (2013) Curr Drug Targets, 14, pp. 571-577 Fish, R.J., Neerman-Arbez, M., Fibrinogen gene regulation (2012) Thromb Haemost, 108, pp. 419-426 Yusuf, S., Lessem, J., Jha, P., Lonn, E., Primary and secondary prevention of myocardial infarction and strokes: An update of randomly allocated, controlled trials (1993) Journal of Hypertension, 11 (SUPPL. 4), pp. S61-S73 Meade, T.W., Haemostatic function and arterial disease (1994) British Medical Bulletin, 50 (4), pp. 755-775 Shu, H., Blomback, M., Gina, Y., Sinha, R., Henschen -Edman, A.H., Modified clotting properties of fibrinogen in the presence of acetylsalicylic acid in a purified system (2001) Annals of the New York Academy of Sciences, 936, pp. 531-535 Caspary, E.A., Studies on the acetylation of human fibrinogen (1956) Biochem J, 62, pp. 507-512